SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-021925
Filing Date
2020-05-06
Accepted
2020-05-06 16:09:27
Documents
14
Period of Report
2020-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q2 2020 EARNINGS RELEASE enta-8k_20200506.htm   iXBRL 8-K 45193
2 EX-99.1 enta-ex991_6.htm EX-99.1 305100
3 GRAPHIC ga53z3s3edsx000001.jpg GRAPHIC 3526
  Complete submission text file 0001564590-20-021925.txt   496736

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA enta-20200506.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20200506_lab.xml EX-101.LAB 18712
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20200506_pre.xml EX-101.PRE 11167
14 EXTRACTED XBRL INSTANCE DOCUMENT enta-8k_20200506_htm.xml XML 3400
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 20852677
SIC: 2834 Pharmaceutical Preparations